Researchers are excited about this new drug, a novel dual agonist showing promising results in early trials for size reduction . It functions by impacting two pathways : GLP-1 and GIP, which , when https://nikolaswete602800.blogozz.com/39631279/a-new-possibility-for-weight-reduction